Sumitomo Mitsui Trust Holdings, Inc. United Therapeutics Corp Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $134 Billion
- Q2 2024
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 99,834 shares of UTHR stock, worth $35.2 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
99,834
Previous 101,042
1.2%
Holding current value
$35.2 Million
Previous $23.2 Million
37.01%
% of portfolio
0.02%
Previous 0.02%
Shares
27 transactions
Others Institutions Holding UTHR
# of Institutions
619Shares Held
45MCall Options Held
368KPut Options Held
410K-
Black Rock Inc. New York, NY5.47MShares$1.93 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.42MShares$1.56 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.29MShares$1.16 Billion0.19% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.01 Billion12.43% of portfolio
-
State Street Corp Boston, MA2.29MShares$810 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16.1B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...